Applying a radiomics approach to predict prognosis of lung cancer patients
- 24 March 2016
- conference paper
- Published by SPIE-Intl Soc Optical Eng
- Vol. 9785, 97851E
Abstract
Radiomics is an emerging technology to decode tumor phenotype based on quantitative analysis of image features computed from radiographic images. In this study, we applied Radiomics concept to investigate the association among the CT image features of lung tumors, which are either quantitatively computed or subjectively rated by radiologists, and two genomic biomarkers namely, protein expression of the excision repair cross-complementing 1 (ERCC1) genes and a regulatory subunit of ribonucleotide reductase (RRM1), in predicting disease-free survival (DFS) of lung cancer patients after surgery. An image dataset involving 94 patients was used. Among them, 20 had cancer recurrence within 3 years, while 74 patients remained DFS. After tumor segmentation, 35 image features were computed from CT images. Using the Weka data mining software package, we selected 10 non-redundant image features. Applying a SMOTE algorithm to generate synthetic data to balance case numbers in two DFS (“yes” and “no”) groups and a leave-one-case-out training/testing method, we optimized and compared a number of machine learning classifiers using (1) quantitative image (QI) features, (2) subjective rated (SR) features, and (3) genomic biomarkers (GB). Data analyses showed relatively lower correlation among the QI, SR and GB prediction results (with Pearson correlation coefficients < 0.5 including between ERCC1 and RRM1 biomarkers). By using area under ROC curve as an assessment index, the QI, SR and GB based classifiers yielded AUC = 0.89±0.04, 0.73±0.06 and 0.76±0.07, respectively, which showed that all three types of features had prediction power (AUC>0.5). Among them, using QI yielded the highest performance.Keywords
This publication has 20 references indexed in Scilit:
- Screening for Lung Cancer With Low-Dose Computed Tomography: A Systematic Review to Update the U.S. Preventive Services Task Force RecommendationAnnals of Internal Medicine, 2013
- Radiomics: Extracting more information from medical images using advanced feature analysisEuropean Journal of Cancer, 2012
- How close are we to customizing chemotherapy in early non-small cell lung cancer?Therapeutic Advances in Medical Oncology, 2011
- ERCC1 and RRM1 in the International Adjuvant Lung Trial by Automated Quantitative in Situ AnalysisThe American Journal of Pathology, 2011
- Screening for Epidermal Growth Factor Receptor Mutations in Lung CancerNew England Journal of Medicine, 2009
- A tense situation: forcing tumour progressionNature Reviews Cancer, 2009
- Quantitative imaging biomarkers in the clinical development of targeted therapeutics: current and future perspectivesThe Lancet Oncology, 2008
- Computed Tomography Screening and Lung Cancer OutcomesJAMA, 2007
- Prognostic Implications of Cell Cycle, Apoptosis, and Angiogenesis Biomarkers in Non–Small Cell Lung Cancer: A ReviewClinical Cancer Research, 2005
- Mass Spectrometry as a Diagnostic and a Cancer Biomarker Discovery ToolMolecular & Cellular Proteomics, 2004